Concepedia

B. Bregman

BB

Statistics

Publications

8

Citations

225

H-Index

8

Active since

1998

Affiliations

Bristol-Myers Squibb (France)(Current)

Bristol-Myers Squibb (Germany)

Sanofi (France)

Centre Hospitalier Régional Universitaire de Brest

Bristol-Myers Squibb (United States)

B. Bregman is an author at Bristol-Myers Squibb (France) specializing in medicine, model-based economic evaluation, and pharmacoeconomics.

Publications per year

1998–2013

8

Publications

8

A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA

Andrew Palmer, Valentine Wn, R. Chen et al. · Nephrology Dialysis Transplantation · 2007 · 86 citations · Full text

, , +17

Cost-effectiveness modelling of biological treatment sequences in moderate to severe rheumatoid arthritis in France

Alain Saraux, Laure Gossec, Philippe Goupille et al. · Lara D. Veeken · 2010 · 34 citations · Full text

, , +17

Direct Cost-Modeling of Rheumatoid Arthritis According to Disease Activity Categories in France

Ariel Béresniak, Laure Gossec, Philippe Goupille et al. · The Journal of Rheumatology · 2010 · 28 citations · Full text

, , +17

Management of chronic myeloid leukaemia in clinical practice in France: results of the French subset of patients from the UNIC study

Mauricette Michallet, Michel Tulliez, Sélim Corm et al. · Current Medical Research and Opinion · 2009 · 24 citations

, , +13

Cost-consequence analysis in a French setting of screening and optimal treatment of nephropathy in hypertensive patients with type 2 diabetes

R. Chen, WJ Valentine, S Roze et al. · Diabetes & Metabolism · 2006 · 18 citations · Full text

, , +16

1–5 of 8